417 related articles for article (PubMed ID: 9260696)
1. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
2. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
[TBL] [Abstract][Full Text] [Related]
3. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.
Tugizov S; Wang Y; Qadri I; Navarro D; Maidji E; Pereira L
Virology; 1995 Jun; 209(2):580-91. PubMed ID: 7778290
[TBL] [Abstract][Full Text] [Related]
4. Location, location, timing: analysis of cytomegalovirus epitopes for neutralizing antibodies.
Schrader JW; McLean GR
Immunol Lett; 2007 Sep; 112(1):58-60. PubMed ID: 17714794
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
6. Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.
Britt WJ; Jarvis MA; Drummond DD; Mach M
J Virol; 2005 Apr; 79(7):4066-79. PubMed ID: 15767408
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells.
Navarro D; Paz P; Tugizov S; Topp K; La Vail J; Pereira L
Virology; 1993 Nov; 197(1):143-58. PubMed ID: 7692667
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
Eggers M; Radsak K; Enders G; Reschke M
J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
[TBL] [Abstract][Full Text] [Related]
9. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
10. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
[TBL] [Abstract][Full Text] [Related]
12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
[TBL] [Abstract][Full Text] [Related]
16. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.
Lilleri D; Kabanova A; Lanzavecchia A; Gerna G
J Clin Immunol; 2012 Dec; 32(6):1324-31. PubMed ID: 22836657
[TBL] [Abstract][Full Text] [Related]
18. Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties.
Barrios Y; Knör S; Lantto J; Mach M; Ohlin M
Mol Immunol; 2007 Feb; 44(5):680-90. PubMed ID: 16824601
[TBL] [Abstract][Full Text] [Related]
19. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals.
Ayata M; Sugano T; Murayama T; Sakamuro D; Takegami T; Matsumoto Y; Furukawa T
J Med Virol; 1994 Aug; 43(4):386-92. PubMed ID: 7525866
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.
Urban M; Klein M; Britt WJ; Hassfurther E; Mach M
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1537-47. PubMed ID: 8757997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
